NG
Nicolas Guyon-Gellin
Vice President Corporate Development And Strategy at Enyo Pharma
View Nicolas's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Vice President Corporate Development And Strategy
Apr 2017 - Present · 7 years and 8 months
Sell Side Analyst
Mar 2014 - Mar 2017 · 3 years
Sell Side Analyst
Jul 2010 - Jan 2014 · 3 years and 6 months
Company Details
11-50 Employees
ENYO Pharma is developing innovative therapeutics based on fibrolytic and anti-inflammatory properties for diseases with impaired kidney function.
The company is conducting Phase 2 trials with its lead compound Vonafexor in Chronic Kidney Diseases (CKD) and rare kidney disease such as Alport syndrome, and liver diseases (such as Non-Alcoholic SteatoHepatitis, NASH).
Liver-related infectious diseases such as chronic Hepatitis B and Hepatitis D are also addressed with Vonafexor.
Website
Year Founded
2014
Social Media
LinkedinTwitter
Industry
Biotechnology Research, Medical and pharmaceutical research, Research and testing, IT, Internet, R&D, Research, general
HQ Location
60 avenue Rockefeller, 69008 LYON, France
Bioserra 1, Bâtiment B
Lyon, Rhône-Alpes 69008, FR
Keywords
--
Contact Details
- Email AddressN**@enyopharma.comReveal Email
- Phone Number(xxx)xxx-xxxxReveal Phone
You May Also Interested In
- MTDetailsMarie ThimonnierInfirmiã Re Puericultrice En NeonatWorked together at Greater Paris University Hospitals Ap Hp
- DSDetailsDalite SchindlerWorked together at Greater Paris University Hospitals Ap Hp
- AGDetailsAmar GuedriAcheteur PublicWorked together at Greater Paris University Hospitals Ap Hp
Find verified contacts of Nicolas Guyon-Gellin in seconds from 700M people profiles. Start now!
Continue with GoogleNo Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.